Cargando…

Polyclonal Immunoglobulin Recovery after Autologous Stem Cell Transplantation Is an Independent Prognostic Factor for Survival Outcome in Patients with Multiple Myeloma

We retrospectively analyzed multiple myeloma (MM) patients who underwent autologous stem cell transplantation (ASCT) without maintenance therapy to assess the impact of recovery of normal immunoglobulin (Ig) on clinical outcomes. The recovery of polyclonal Ig was defined as normalization of all valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ozaki, Shuji, Harada, Takeshi, Yagi, Hikaru, Sekimoto, Etsuko, Shibata, Hironobu, Shigekiyo, Toshio, Fujii, Shiro, Nakamura, Shingen, Miki, Hirokazu, Kagawa, Kumiko, Abe, Masahiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016673/ https://www.ncbi.nlm.nih.gov/pubmed/31861479 http://dx.doi.org/10.3390/cancers12010012

Ejemplares similares

Systemic osteosclerosis associated with primary bone marrow B‐cell lymphoma
por: Ozaki, Shuji, et al.
Publicado: (2023)

Inhibition of TACE Activity Enhances the Susceptibility of Myeloma Cells to TRAIL
por: Kagawa, Kumiko, et al.
Publicado: (2012)

Constitutional pericentric inversion of chromosome 16, inv(16)(p13.1q22), mimicking acute myeloid leukemia
por: Ozaki, Shuji, et al.
Publicado: (2022)

Combination with a Defucosylated Anti-HM1.24 Monoclonal Antibody plus Lenalidomide Induces Marked ADCC against Myeloma Cells and Their Progenitors
por: Harada, Takeshi, et al.
Publicado: (2013)

Primary CD30-positive Diffuse Large B-cell Lymphoma in the Superior Vena Cava
por: Nakamura, Shingen, et al.
Publicado: (2017)

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
por: Iwasa, Masami, et al.
Publicado: (2019)

TGF-β Inhibition Restores Terminal Osteoblast Differentiation to Suppress Myeloma Growth
por: Takeuchi, Kyoko, et al.
Publicado: (2010)

Acute Myeloid Leukemia Developing with Acute Pancreatitis Mimicking Autoimmune Pancreatitis
por: Sumitani, Ryohei, et al.
Publicado: (2021)

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells
por: Nakano, Ayako, et al.
Publicado: (2011)

Novel antimyeloma therapeutic option with inhibition of the HDAC1-IRF4 axis and PIM kinase
por: Harada, Takeshi, et al.
Publicado: (2022)

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma
por: Teramachi, Jumpei, et al.
Publicado: (2020)

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors
por: Bat-Erdene, Ariunzaya, et al.
Publicado: (2016)

A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alteration
por: Amachi, Ryota, et al.
Publicado: (2016)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat
por: Ashtar, Mohannad, et al.
Publicado: (2020)

Effective impairment of myeloma cells and their progenitors by hyperthermia
por: Miki, Hirokazu, et al.
Publicado: (2017)

Relationship between polyclonal immunoglobulin therapy and colonization by Candida spp.
por: Serafini, G, et al.
Publicado: (2012)

Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma
por: Yamashita, Michiko, et al.
Publicado: (2015)

The importance of retaining physical functions to prevent skeletal‐related events in multiple myeloma patients with bone disease
por: Miki, Hirokazu, et al.
Publicado: (2022)

Induction of polyclonal antibody synthesis by human allogeneic and autologous helper factors
Publicado: (1979)

Polyclonal immunoglobulins for COVID-19 pre-exposure prophylaxis in immunocompromised patients
por: Focosi, Daniele, et al.
Publicado: (2023)

Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma
por: González-Calle, Verónica, et al.
Publicado: (2017)

Screening of Multiple Myeloma by Polyclonal Rabbit Anti-Human Plasmacytoma Cell Immunoglobulin
por: Mu, Bo, et al.
Publicado: (2013)

Indigenous production, characterization and evaluation of polyclonal antibody against Camelus dromedarius immunoglobulin
por: Yektaseresht, Azadeh, et al.
Publicado: (2022)

Elevated serum polyclonal immunoglobulin free light chains in patients with severe asthma
por: Basile, Umberto, et al.
Publicado: (2023)

Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation
por: Hanson, Derek James, et al.
Publicado: (2015)

Magnetically Responsive Smart Nanoparticles for Cancer Treatment with a Combination of Magnetic Hyperthermia and Remote-Control Drug Release
por: Hayashi, Koichiro, et al.
Publicado: (2014)

Superparamagnetic Nanoparticle Clusters for Cancer Theranostics Combining Magnetic Resonance Imaging and Hyperthermia Treatment
por: Hayashi, Koichiro, et al.
Publicado: (2013)

Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia
por: Sarkar, Debalina, et al.
Publicado: (2014)

Production, Characterization and Applications for Toxoplasma gondii-Specific Polyclonal Chicken Egg Yolk Immunoglobulins
por: Ferreira Júnior, Álvaro, et al.
Publicado: (2012)

Efficacy of High-Dose Polyclonal Intravenous Immunoglobulin in COVID-19: A Systematic Review
por: Focosi, Daniele, et al.
Publicado: (2022)

Feasibility of Polyclonal Avian Immunoglobulins (IgY) as Prophylaxis against Human Norovirus Infection
por: Artman, Chad, et al.
Publicado: (2022)

Igm-enriched polyclonal immunoglobulins in an experimental model of gram negative pneumonia developing septic shock
por: Vaschetto, R, et al.
Publicado: (2015)

Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G
por: Nasiri, Hadi, et al.
Publicado: (2017)

Production and Quality Assurance of Human Polyclonal Hyperimmune Immunoglobulins Against SARS-CoV-2
por: Burnouf, Thierry, et al.
Publicado: (2022)

Long-term survival and polyclonal immunoglobulin reconstitution after allogeneic stem cell transplantation in multiple myeloma
por: Eisfeld, Christine, et al.
Publicado: (2020)

Cell Population Data and Serum Polyclonal Immunoglobulin Free Light Chains in the Assessment of COVID-19 Severity
por: Małecka-Giełdowska, Milena, et al.
Publicado: (2021)

Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma: Past, Present, and Future
por: Ozaki, Shuji, et al.
Publicado: (2014)

Increased polyclonal immunoglobulin reactivity toward human and bacterial proteins is associated with clinical protection in human Plasmodium infection
por: Fesel, Constantin, et al.
Publicado: (2005)

Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
por: Chauvet, Sophie, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4vcm06s0lgak2q0i0oacdjfp1u